Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Dopamine D1/D2 coactivation maximizes metabolic responses in obese mice

Sep. 18, 1997

TheraTech and Astra sign agreement for Androderm distribution

Sep. 18, 1997

New raloxifene analogue from Lilly is a potent SERM

Sep. 18, 1997

Novel osteoclast resorption inhibitor isolated by Swiss investigators

Sep. 18, 1997

Known antidiabetic agent modulates glucocorticoid response in osteoclasts

Sep. 18, 1997

Role of osteoprotegerin in skeletal metabolism elucidated

Sep. 18, 1997

Separation of antiobesity and antidiabetic effects of beta3-adrenoceptor agonist established in rats

Sep. 18, 1997

Growth hormone antagonist enters phase II

Sep. 18, 1997

Duke University granted orphan drug status for Pompe's disease therapy

Sep. 17, 1997

Role of IL-1 receptors in osteoporosis elucidated

Sep. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...